Author(s)
Schaetz L1, Pathak P2, Rimner T3, Fang J4, Chandrasekhar D5, Vandervoort L5, Mueller J6, Gantenbein AR7
1Novartis, Switzerland, 2Novartis Ireland Ltd., Dublin, D, Ireland, 3Medgate Teleclinic, Basel, Switzerland, 4Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 5Healint Pte Ltd., Singapore, Singapore, 6Novartis, Basel, Switzerland, 7RehaClinic, Bad Zurzach, Switzerland
OBJECTIVES : To assess participants’ satisfaction with a Migraine Care program offered by a healthcare company as a complimentary service within its wellness program for its Swiss-based employees and their family members. The program objective was to foster patient empowerment to multidisciplinary approaches in the management of their migraine. METHODS : Participants receive six sessions (monthly) of individualized telecoaching from a specialized nurse and through a specially developed module on the Migraine Buddy smartphone application. The study participants were evaluated through a series of questionnaires including Migraine Disability Assessment and Patient Activation Measure. An exit questionnaire was also administered at the end of the program (at month 6) to collect feedback from the study participants to measure satisfaction level of the services offered. RESULTS : Of the 141 participants enrolled into the study, 79 completed the program and provided their feedback at month 6. A total of 90% of the participants who completed the study and participated in the exit survey reported feeling improved (under ‘minimally’, ‘much’ and ‘very much’ categories) compared to baseline on the Patient Global Impression of Change scale. With 69% of the participants categorized as promoters (very satisfied) and 6% as detractors (not at all satisfied), the net promoter score was estimated as 63. While 43% participants reported that the program met their expectations, 33% and 22% reported that the program ‘exceeded’ and ‘greatly exceeded’ their expectations, respectively. When prompted for self-reported progress towards migraine goals and how the program helped them to better manage their migraine, 77% and 85% responded in favor of the program. CONCLUSIONS : The results demonstrate that an employer-sponsored migraine disease management program resulted in greater clinical improvements in employees’ migraine and very high levels of satisfaction with the program informing other companies that such programs could be great enhancements of their wellness programs.
Conference/Value in Health Info
2020-05, ISPOR 2020, Orlando, FL, USA
Value in Health, Volume 23, Issue 5, S1 (May 2020)
Code
PND73
Topic
Health Service Delivery & Process of Care, Patient-Centered Research
Topic Subcategory
Disease Management, Patient Engagement, Patient-reported Outcomes & Quality of Life Outcomes, Stated Preference & Patient Satisfaction
Disease
Neurological Disorders